1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 12,200 | 12,500 | 17:30 | |
| 12,186 | 12,484 | 17:31 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17:14 | MiniMed launches Instinct sensors made by Abbott with insulin delivery tech in Europe | 2 | MassDevice | ||
| 15:00 | MiniMed launches Instinct sensors in Europe giving people with diabetes more sensor choice with the same proven outcomes | 312 | PR Newswire | MiniMed automated insulin delivery and smart MDI systems can now be paired with Instinct and Instinct Go, made by Abbott, the smallest, longest-wear sensors in the company's portfolioNORTHRIDGE... ► Artikel lesen | |
| Mi | MiniMed begins miniature Flex pump rollout in US | 1 | MassDevice | ||
| 12.06. | Benchmark reiterates MiniMed Group stock rating on product launches | 1 | Investing.com | ||
| 04.06. | Benchmark reiterates Buy on MiniMed stock, cites product launches | 2 | Investing.com | ||
| 04.06. | Piper Sandler bestätigt "Neutral"-Rating für MiniMed mit Kursziel von 16 $ | 1 | Investing.com Deutsch | ||
| 04.06. | Piper Sandler reiterates Neutral rating on MiniMed stock at $16 | 1 | Investing.com | ||
| MINIMED GROUP Aktie jetzt für 0€ handeln | |||||
| 03.06. | MiniMed Group Shares Surge 14% Over Strong Revenue Growth In Q4 | 1 | RTTNews | ||
| 03.06. | Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday | 30 | Benzinga.com | ||
| 03.06. | MiniMed meldet starkes Wachstum in Q4 2026 - Aktie legt zu | 16 | Investing.com Deutsch | ||
| 03.06. | Full Transcript: Minimed Group Q4 2026 Earnings Call | 13 | Benzinga.com | ||
| 03.06. | MiniMed adds Abbott dual glucose-ketone sensor to portfolio, posts Q4 sales beat | 2 | MassDevice | ||
| 03.06. | Minimed Reports Wider Q4 Loss Despite Higher Revenue, Shares Rise In Pre-market | 3 | RTTNews | ||
| 03.06. | MiniMed reports mixed Q4 results; gives FY2027 outlook | 2 | Seeking Alpha | ||
| 03.06. | MiniMed erweitert Partnerschaft mit Abbott für duale Glukose-Keton-Sensoren | 12 | Investing.com Deutsch | ||
| 03.06. | MiniMed partners with Abbott on dual glucose-ketone sensors | 4 | Investing.com | ||
| 03.06. | MiniMed Group, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 03.06. | MiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlook | 193 | PR Newswire | Continued momentum in Q4, with net sales of $837 million growing 16% as reported and 9% organic year-over-year
Record annual net sales performance surpasses $3B for first time, growing... ► Artikel lesen | |
| 26.05. | MiniMed launches MiniMed Go smart multiple daily injection system in US | 1 | MassDevice | ||
| 21.05. | New data backs MiniMed 780G pump, SmartGuard algorithm across CGM types | - | MassDevice |
1 2 3 4 5 Weiter >>
88 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,490 | -0,31 % | HEALWELL AI informiert über Neuigkeiten aus dem Unternehmen: Annahme der Forschungsergebnisse aus provinzübergreifendem KI-Pilotprojekt beim AMIA-Symposium und Stärkung der Bilanz durch SpaceX-Beteiligung | - HEALWELL hat erfolgreich ein Pilotprojekt zur Bewertung seiner auf DARWEN basierenden KI-Lösungen SMART Summary und SMART Search in mehreren kanadischen Provinzen
abgeschlossen. Das... ► Artikel lesen | |
| INSULET | 120,90 | -0,53 % | This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday | ||
| LIFEWARD | 6,970 | -1,34 % | Lifeward Ltd.: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform | Veteran physician- medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience- mobility technologies, and metabolic disease... ► Artikel lesen | |
| IMUNON | 1,620 | 0,00 % | Imunon, Inc.: IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification | On track for enrollment of 80 participants by Q1 2027 Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer... ► Artikel lesen | |
| LANTHEUS | 93,60 | +0,65 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 36,200 | 0,00 % | Evercore ISI stuft Inspire Medical Aktie wegen Kodierungsproblemen herab | ||
| INSPIREMD | 0,635 | +0,79 % | InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR | ||
| GT BIOPHARMA | 0,490 | -0,08 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| INOGEN | 5,550 | 0,00 % | Inogen Inc - S-8, Securities to be offered to employees in employee benefit plans | ||
| MYOMO | 1,118 | +0,90 % | Myomo übertrifft Q1-Prognosen, Aktie gibt dennoch nach | ||
| INTELLIGENT BIO SOLUTIONS | 2,290 | -3,78 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry | Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 3,320 | +2,15 % | Incannex Healthcare: Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility | NEW YORK and MELBOURNE, Australia, June 10, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| HEARTFLOW | 34,185 | +1,02 % | Heartflow, Inc. - 8-K, Current Report | ||
| GLUCOTRACK | 0,360 | -1,07 % | GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,570 | -2,16 % | Lexaria Bioscience Corp.: Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule | Potentially Valuable Novel Compositions Being InvestigatedLexaria Also Receives Additional New Granted Patent KELOWNA, BC / ACCESS Newswire / June 23, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX)... ► Artikel lesen |
MINIMED GROUP INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,040 (+0,32 %) liegt der Kurs bei 12,500 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MINIMED GROUP INC finden Sie auf Wallstreet Online.